BioBridgeXAll companies

Senti Biosciences Holdings, Inc.

Biotechnology company · South San Francisco, California, United States · Nasdaq: SNTI

Senti Biosciences Holdings, Inc. is a biotechnology company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker SNTI. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Senti Biosciences Holdings at a glance

Typebiotechnology company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2021
Stock listingNasdaq: SNTI
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1854270

What does Senti Biosciences Holdings do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $10 million sold (2026).

Frequently asked questions about Senti Biosciences Holdings

Where is Senti Biosciences Holdings headquartered?

Senti Biosciences Holdings, Inc. is headquartered in South San Francisco, California, United States.

What does Senti Biosciences Holdings do?

Senti Biosciences Holdings, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Senti Biosciences Holdings a public company?

Yes. Senti Biosciences Holdings, Inc. trades on Nasdaq under the ticker SNTI.

When was Senti Biosciences Holdings founded?

The earliest incorporation on record for Senti Biosciences Holdings, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences